We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





New Rapid Coronavirus Test Gives Results in Just 15 Minutes

By LabMedica International staff writers
Posted on 28 Mar 2020
Print article
Image: Sensitest’s Corona Rapid test for professional use (Photo courtesy of Sensitest International)
Image: Sensitest’s Corona Rapid test for professional use (Photo courtesy of Sensitest International)
Sensitest International (Delfgauw, The Netherlands), has developed a new coronavirus test that can show whether a patient has the IgM or IgG antibodies of the coronavirus (Covid-19) within 15 minutes. Sensitest’s Corona Rapid test for professional use is the only rapid test certified in the EU with a CE certificate issued by a European Notified Body. The product has been clinically tested with 596 patients, out of which 361 confirmed positive and 235 confirmed negative.

The rapid test consists of a test cassette, a buffer liquid, a pipette and an English manual. The Corona Rapid Test gives the test result in 15 minutes whether a patient has produced antibodies for the Corona virus (IgG / IgM). Similar to a pregnancy stick, the test cassette works with a drop of blood which is first placed in the collection hole of the test cassette after which a few drops of the buffer liquid are added. The test result can be read after 15 minutes and the result is positive for two lines in the test window and negative with one line. One box contains 20 test cassettes, 20 pipettes, one instruction manual and one bottle of buffer liquid. The product is only supplied to professional customers, such as hospitals, laboratories and healthcare institutions.

Related Links:
Sensitest International

Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit
New
Calprotectin Assay
Fecal Calprotectin ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.